---
title: "I'm conducting a systematic review on the accuracy of rapid diagnostic tests for infectious diseases. Help me: 1) Use PICO format adapted for diagnostic questions (Population"
description: "AI model comparison: I'm conducting a systematic review on the accuracy of rapid diagnostic tests for infectious diseases..."
date: 2025-10-15
category: comparison
layout: Clean
tags:
  - ChatGPT
  - Gemini
  - AI Comparison
author: SNEOS Community
head:
  - - meta
    - name: description
      content: "AI model comparison: I'm conducting a systematic review on the accuracy of rapid diagnostic tests for infectious diseases. Help me: 1) Use PI..."
---

<ChatComparison
  title="I'm conducting a systematic review on the accuracy of rapid diagnostic tests for infectious diseases. Help me: 1) Use PICO format adapted for diagnostic questions (Population"
  prompt="I'm conducting a systematic review on the accuracy of rapid diagnostic tests for infectious diseases. Help me: 1) Use PICO format adapted for diagnostic questions (Population"
  :responses='{"ChatGPT": "Certainly! When conducting a systematic review, especially for diagnostic tests, the PICO format can be adapted to focus on the relevant components: \n\n1. **Population**: Describe the population or specific group of individuals you are interested in. This could include specific demographics, such as age, sex, or health status, as well as the disease or condition they are being tested for.\n   \n2. **Intervention**: In the context of diagnostic studies, the \u0022intervention\u0022 refers to the rapid diagnostic test being evaluated.\n\n3. **Comparison**: This might involve comparing the rapid diagnostic test to a gold standard or reference standard test. If no comparison is available, you might note that.\n\n4. **Outcomes**: Specify the outcomes you are measuring, which could include sensitivity, specificity, positive predictive value, negative predictive value, or overall accuracy of the rapid diagnostic tests.\n\n### Example of PICO format for your systematic review:\n\n- **Population**: Adults and children presenting with suspected infectious diseases (e.g., influenza, COVID-19, strep throat).\n  \n- **Intervention**: Rapid diagnostic tests (e.g., rapid antigen tests, molecular tests).\n\n- **Comparison**: Standard laboratory tests (e.g., PCR tests, culture methods) or no intervention (if no gold standard exists).\n\n- **Outcome**: Accuracy measures (sensitivity, specificity, positive predictive value, negative predictive value).\n\n### Full Example:\n- **P**: Adults and children presenting with suspected influenza or COVID-19.\n- **I**: Rapid antigen tests for influenza and COVID-19.\n- **C**: Standard PCR tests.\n- **O**: Sensitivity and specificity of rapid tests compared to PCR tests.\n\nThis format will help you clearly articulate your research question and guide your systematic review process. If you have specific diseases or tests in mind, we can refine this further!", "Gemini": "This is an excellent and crucial step for your systematic review! Adapting PICO for diagnostic accuracy questions is key to a well-defined search and clear review objectives.\n\n---\n\n## 1) PICO Format Adapted for Diagnostic Accuracy Questions\n\nFor diagnostic accuracy studies, the \u0022C\u0022 (Comparator) is usually the **Reference Standard** or \u0022Gold Standard\u0022 test, and the \u0022O\u0022 (Outcome) specifically refers to measures of **diagnostic accuracy**. We\u0027ll also often add \u0022S\u0022 for Study Design.\n\n**Your PICO (Adapted for Diagnostic Accuracy):**\n\n*   **P (Population/Patients):** Patients suspected of having a **specific infectious disease** or conditions that warrant testing for a specific infectious disease.\n    *   *Example:* Adult patients presenting with fever in malaria-endemic areas.\n    *   *Example:* Individuals undergoing routine screening for HIV.\n    *   *Example:* Patients with respiratory symptoms suspected of having influenza or COVID-19.\n\n*   **I (Index Test/Intervention):** The **Rapid Diagnostic Test (RDT)** being evaluated for its diagnostic performance.\n    *   *Example:* Malaria antigen-detecting rapid diagnostic tests (Ag-RDTs).\n    *   *Example:* HIV self-tests (oral fluid or blood-based).\n    *   *Example:* SARS-CoV-2 antigen rapid diagnostic tests.\n\n*   **C (Comparator/Reference Standard):** The established **\u0022gold standard\u0022 or best available reference test** against which the RDT\u0027s accuracy is measured.\n    *   *Example:* Thick and thin blood smear microscopy (for malaria).\n    *   *Example:* Laboratory-based enzyme immunoassay (EIA) confirmed by Western blot or nucleic acid test (NAT) (for HIV).\n    *   *Example:* Reverse transcription polymerase chain reaction (RT-PCR) (for SARS-CoV-2 or influenza).\n\n*   **O (Outcome):** Measures of **diagnostic accuracy**.\n    *   *Specific measures:* Sensitivity, Specificity, Positive Predictive Value (PPV), Negative Predictive Value (NPV), Likelihood Ratios (Positive LR, Negative LR), Diagnostic Odds Ratio (DOR), Area Under the Receiver Operating Characteristic (ROC) curve (AUC).\n\n*   **S (Study Design - Optional but Recommended):** Types of studies included.\n    *   *Specific design:* Diagnostic accuracy studies, cross-sectional studies, cohort studies (where the index test and reference standard are applied to the same participants).\n\n---\n\n**Crucial Note:** You MUST narrow down the \u0022specific infectious disease\u0022 for your review to be manageable and meaningful. A systematic review on *all* RDTs for *all* infectious diseases would be impossible to conduct.\n\n---\n\n## 2) Search Strategy for PubMed/MEDLINE, Embase, and Cochrane Library\n\nBelow is a comprehensive search strategy broken down by concept. You will combine these concepts using Boolean operators (AND, OR). Remember to adapt for specific database syntax and controlled vocabulary (MeSH for PubMed, Emtree for Embase).\n\n**General Principles:**\n*   Use \u0060OR\u0060 within each concept group to broaden your search for that concept.\n*   Use \u0060AND\u0060 between concept groups to combine them and narrow your search to relevant studies.\n*   Use \u0060*\u0060 for truncation to capture variations (e.g., \u0060diagnos*\u0060 will find diagnosis, diagnose, diagnostic).\n*   Use \u0060[tiab]\u0060 for PubMed/MEDLINE or \u0060:ab,ti\u0060 for Embase to search in Title and Abstract fields.\n\n---\n\n### **Concept 1: Population / Infectious Disease (SPECIFY YOUR DISEASE HERE!)**\n\nThis is where you\u0027ll define your specific infectious disease.\n\n**Example for Malaria:**\n\n*   **PubMed/MEDLINE (MeSH \u0026 Keywords):**\n    *   \u0060(\u0022Malaria\u0022[Mesh] OR \u0022malaria\u0022[tiab] OR \u0022Plasmodium\u0022[tiab])\u0060\n\n*   **Embase (Emtree \u0026 Keywords):**\n    *   \u0060(\u0027malaria\u0027/exp OR malaria:ab,ti OR plasmodium:ab,ti)\u0060\n\n*   **Cochrane Library (MeSH \u0026 Keywords):**\n    *   \u0060(\u0022Malaria\u0022[MeSH] OR malaria:ti,ab OR Plasmodium:ti,ab)\u0060\n\n**Example for COVID-19:**\n\n*   **PubMed/MEDLINE (MeSH \u0026 Keywords):**\n    *   \u0060(\u0022COVID-19\u0022[Mesh] OR \u0022COVID 19\u0022[tiab] OR \u0022SARS-CoV-2\u0022[Mesh] OR \u0022SARS-CoV-2\u0022[tiab] OR \u0022coronavirus disease 19\u0022[tiab])\u0060\n\n*   **Embase (Emtree \u0026 Keywords):**\n    *   \u0060(\u0027covid-19\u0027/exp OR covid-19:ab,ti OR \u0027sars cov 2\u0027/exp OR sars-cov-2:ab,ti OR \u0027coronavirus disease 19\u0027:ab,ti)\u0060\n\n*   **Cochrane Library (MeSH \u0026 Keywords):**\n    *   \u0060(\u0022COVID-19\u0022[MeSH] OR COVID-19:ti,ab OR \u0022SARS-CoV-2\u0022[MeSH] OR SARS-CoV-2:ti,ab)\u0060\n\n---\n\n### **Concept 2: Index Test (Rapid Diagnostic Tests)**\n\n*   **PubMed/MEDLINE (MeSH \u0026 Keywords):**\n    *   \u0060(\u0022Rapid Diagnostic Test\u0022[Mesh] OR \u0022Point-of-Care Systems\u0022[Mesh] OR \u0022rapid diagnostic test*\u0022[tiab] OR \u0022RDT*\u0022[tiab] OR \u0022point of care test*\u0022[tiab] OR \u0022POCT\u0022[tiab] OR \u0022lateral flow\u0022[tiab] OR \u0022immunochromatographic\u0022[tiab] OR \u0022antigen test*\u0022[tiab] OR \u0022antibody test*\u0022[tiab] OR \u0022near patient test*\u0022[tiab] OR \u0022bedside test*\u0022[tiab] OR \u0022dipstick\u0022[tiab] OR \u0022strip test*\u0022[tiab] OR \u0022quick test*\u0022[tiab])\u0060\n\n*   **Embase (Emtree \u0026 Keywords):**\n    *   \u0060(\u0027rapid diagnostic test\u0027/exp OR \u0027point of care system\u0027/exp OR rapid diagnostic test*:ab,ti OR RDT*:ab,ti OR point of care test*:ab,ti OR POCT:ab,ti OR lateral flow:ab,ti OR immunochromatographic:ab,ti OR antigen test*:ab,ti OR antibody test*:ab,ti OR near patient test*:ab,ti OR bedside test*:ab,ti OR dipstick:ab,ti OR strip test*:ab,ti OR quick test*:ab,ti)\u0060\n\n*   **Cochrane Library (MeSH \u0026 Keywords):**\n    *   \u0060(\u0022Rapid Diagnostic Test\u0022[MeSH] OR \u0022Point-of-Care Systems\u0022[MeSH] OR rapid diagnostic test*:ti,ab OR RDT*:ti,ab OR point of care test*:ti,ab OR POCT:ti,ab OR lateral flow:ti,ab OR immunochromatographic:ti,ab OR antigen test*:ti,ab OR antibody test*:ti,ab OR near patient test*:ti,ab OR bedside test*:ti,ab OR dipstick:ti,ab OR strip test*:ti,ab OR quick test*:ti,ab)\u0060\n\n---\n\n### **Concept 3: Outcome (Diagnostic Accuracy Measures)**\n\n*   **PubMed/MEDLINE (MeSH \u0026 Keywords):**\n    *   \u0060(\u0022Diagnostic Accuracy\u0022[Mesh] OR \u0022Sensitivity and Specificity\u0022[Mesh] OR \u0022Predictive Value of Tests\u0022[Mesh] OR \u0022accuracy\u0022[tiab] OR \u0022accurate\u0022[tiab] OR \u0022sensitivity\u0022[tiab] OR \u0022specificity\u0022[tiab] OR \u0022predictive value*\u0022[tiab] OR \u0022likelihood ratio*\u0022[tiab] OR \u0022ROC curve*\u0022[tiab] OR \u0022AUC\u0022[tiab] OR \u0022diagnostic performance\u0022[tiab] OR \u0022diagnosis\u0022[tiab] OR \u0022diagnos*\u0022[tiab] OR \u0022false positive*\u0022[tiab] OR \u0022false negative*\u0022[tiab])\u0060\n\n*   **Embase (Emtree \u0026 Keywords):**\n    *   \u0060(\u0027diagnostic accuracy\u0027/exp OR \u0027sensitivity and specificity\u0027/exp OR \u0027predictive value\u0027/exp OR accuracy:ab,ti OR accurate:ab,ti OR sensitivity:ab,ti OR specificity:ab,ti OR predictive value*:ab,ti OR likelihood ratio*:ab,ti OR ROC curve*:ab,ti OR AUC:ab,ti OR diagnostic performance:ab,ti OR diagnosis:ab,ti OR diagnos*:ab,ti OR false positive*:ab,ti OR false negative*:ab,ti)\u0060\n\n*   **Cochrane Library (MeSH \u0026 Keywords):**\n    *   \u0060(\u0022Diagnostic Accuracy\u0022[MeSH] OR \u0022Sensitivity and Specificity\u0022[MeSH] OR \u0022Predictive Value of Tests\u0022[MeSH] OR accuracy:ti,ab OR accurate:ti,ab OR sensitivity:ti,ab OR specificity:ti,ab OR predictive value*:ti,ab OR likelihood ratio*:ti,ab OR ROC curve*:ti,ab OR AUC:ti,ab OR diagnostic performance:ti,ab OR diagnosis:ti,ab OR diagnos*:ti,ab OR false positive*:ti,ab OR false negative*:ti,ab)\u0060\n\n---\n\n### **Concept 4: Study Type (Optional but can help refine)**\n\nThis aims to identify diagnostic accuracy studies directly.\n\n*   **PubMed/MEDLINE (Publication Type \u0026 Keywords):**\n    *   \u0060(\u0022Diagnostic Test Accuracy Study\u0022[pt] OR \u0022Cross-Sectional Studies\u0022[Mesh] OR \u0022diagnostic accuracy study*\u0022[tiab] OR \u0022test performance study*\u0022[tiab] OR \u0022validation study*\u0022[tiab] OR \u0022screening test*\u0022[tiab] OR \u0022diagnosis study*\u0022[tiab] OR \u0022sensitivity specificity study*\u0022[tiab])\u0060\n\n*   **Embase (Emtree \u0026 Keywords):**\n    *   \u0060(\u0027diagnostic accuracy study\u0027/exp OR \u0027cross-sectional study\u0027/exp OR diagnostic accuracy study*:ab,ti OR test performance study*:ab,ti OR validation study*:ab,ti OR screening test*:ab,ti OR diagnosis study*:ab,ti OR sensitivity specificity study*:ab,ti)\u0060\n\n*   **Cochrane Library (Publication Type \u0026 Keywords):**\n    *   \u0060(\u0022Diagnostic Test Accuracy Study\u0022[pt] OR \u0022Cross-Sectional Studies\u0022[MeSH] OR diagnostic accuracy study*:ti,ab OR test performance study*:ti,ab OR validation study*:ti,ab OR screening test*:ti,ab OR diagnosis study*:ti,ab OR sensitivity specificity study*:ti,ab)\u0060\n\n---\n\n### **Putting It All Together (Example for Malaria RDTs):**\n\n**PubMed/MEDLINE:**\n\n\u0060\u0060\u0060\n( (\u0022Malaria\u0022[Mesh] OR \u0022malaria\u0022[tiab] OR \u0022Plasmodium\u0022[tiab]) )\nAND\n( (\u0022Rapid Diagnostic Test\u0022[Mesh] OR \u0022Point-of-Care Systems\u0022[Mesh] OR \u0022rapid diagnostic test*\u0022[tiab] OR \u0022RDT*\u0022[tiab] OR \u0022point of care test*\u0022[tiab] OR \u0022POCT\u0022[tiab] OR \u0022lateral flow\u0022[tiab] OR \u0022immunochromatographic\u0022[tiab] OR \u0022antigen test*\u0022[tiab] OR \u0022antibody test*\u0022[tiab] OR \u0022near patient test*\u0022[tiab] OR \u0022bedside test*\u0022[tiab] OR \u0022dipstick\u0022[tiab] OR \u0022strip test*\u0022[tiab] OR \u0022quick test*\u0022[tiab]) )\nAND\n( (\u0022Diagnostic Accuracy\u0022[Mesh] OR \u0022Sensitivity and Specificity\u0022[Mesh] OR \u0022Predictive Value of Tests\u0022[Mesh] OR \u0022accuracy\u0022[tiab] OR \u0022accurate\u0022[tiab] OR \u0022sensitivity\u0022[tiab] OR \u0022specificity\u0022[tiab] OR \u0022predictive value*\u0022[tiab] OR \u0022likelihood ratio*\u0022[tiab] OR \u0022ROC curve*\u0022[tiab] OR \u0022AUC\u0022[tiab] OR \u0022diagnostic performance\u0022[tiab] OR \u0022diagnosis\u0022[tiab] OR \u0022diagnos*\u0022[tiab] OR \u0022false positive*\u0022[tiab] OR \u0022false negative*\u0022[tiab]) )\nAND\n( (\u0022Diagnostic Test Accuracy Study\u0022[pt] OR \u0022Cross-Sectional Studies\u0022[Mesh] OR \u0022diagnostic accuracy study*\u0022[tiab] OR \u0022test performance study*\u0022[tiab] OR \u0022validation study*\u0022[tiab] OR \u0022screening test*\u0022[tiab] OR \u0022diagnosis study*\u0022[tiab] OR \u0022sensitivity specificity study*\u0022[tiab]) )\n\u0060\u0060\u0060\n\n**Embase:** (Note: Embase often allows direct combination without as many parentheses, but it\u0027s good practice to group)\n\n\u0060\u0060\u0060\n( (\u0027malaria\u0027/exp OR malaria:ab,ti OR plasmodium:ab,ti) )\nAND\n( (\u0027rapid diagnostic test\u0027/exp OR \u0027point of care system\u0027/exp OR rapid diagnostic test*:ab,ti OR RDT*:ab,ti OR point of care test*:ab,ti OR POCT:ab,ti OR lateral flow:ab,ti OR immunochromatographic:ab,ti OR antigen test*:ab,ti OR antibody test*:ab,ti OR near patient test*:ab,ti OR bedside test*:ab,ti OR dipstick:ab,ti OR strip test*:ab,ti OR quick test*:ab,ti) )\nAND\n( (\u0027diagnostic accuracy\u0027/exp OR \u0027sensitivity and specificity\u0027/exp OR \u0027predictive value\u0027/exp OR accuracy:ab,ti OR accurate:ab,ti OR sensitivity:ab,ti OR specificity:ab,ti OR predictive value*:ab,ti OR likelihood ratio*:ab,ti OR ROC curve*:ab,ti OR AUC:ab,ti OR diagnostic performance:ab,ti OR diagnosis:ab,ti OR diagnos*:ab,ti OR false positive*:ab,ti OR false negative*:ab,ti) )\nAND\n( (\u0027diagnostic accuracy study\u0027/exp OR \u0027cross-sectional study\u0027/exp OR diagnostic accuracy study*:ab,ti OR test performance study*:ab,ti OR validation study*:ab,ti OR screening test*:ab,ti OR diagnosis study*:ab,ti OR sensitivity specificity study*:ab,ti) )\n\u0060\u0060\u0060\n\n**Cochrane Library:** (Often the most straightforward, using MeSH and Text Word \u0060[tw]\u0060)\n\n\u0060\u0060\u0060\n(\u0022Malaria\u0022[MeSH] OR malaria:ti,ab OR Plasmodium:ti,ab)\nAND\n(\u0022Rapid Diagnostic Test\u0022[MeSH] OR \u0022Point-of-Care Systems\u0022[MeSH] OR rapid diagnostic test*:ti,ab OR RDT*:ti,ab OR point of care test*:ti,ab OR POCT:ti,ab OR lateral flow:ti,ab OR immunochromatographic:ti,ab OR antigen test*:ti,ab OR antibody test*:ti,ab OR near patient test*:ti,ab OR bedside test*:ti,ab OR dipstick:ti,ab OR strip test*:ti,ab OR quick test*:ti,ab)\nAND\n(\u0022Diagnostic Accuracy\u0022[MeSH] OR \u0022Sensitivity and Specificity\u0022[MeSH] OR \u0022Predictive Value of Tests\u0022[MeSH] OR accuracy:ti,ab OR accurate:ti,ab OR sensitivity:ti,ab OR specificity:ti,ab OR predictive value*:ti,ab OR likelihood ratio*:ti,ab OR ROC curve*:ti,ab OR AUC:ti,ab OR diagnostic performance:ti,ab OR diagnosis:ti,ab OR diagnos*:ti,ab OR false positive*:ti,ab OR false negative*:ti,ab)\nAND\n(\u0022Diagnostic Test Accuracy Study\u0022[pt] OR \u0022Cross-Sectional Studies\u0022[MeSH] OR diagnostic accuracy study*:ti,ab OR test performance study*:ti,ab OR validation study*:ti,ab OR screening test*:ti,ab OR diagnosis study*:ti,ab OR sensitivity specificity study*:ti,ab)\n\u0060\u0060\u0060\n\n---\n\n### **Important Considerations for Your Search:**\n\n1.  **Iterative Process:** Your first search will likely return too many or too few results. Be prepared to refine your terms. Add more synonyms, remove overly broad terms, or adjust \u0060[tiab]\u0060 to specific fields if necessary.\n2.  **Language Restrictions:** Decide if you will include only English-language studies or others. Add a language filter in the database if needed.\n3.  **Date Limits:** Consider if you want to limit by publication date (e.g., last 10 years for newer RDTs, or no limit for comprehensive historical data).\n4.  **Grey Literature:** Don\u0027t forget to search for grey literature (e.g., conference abstracts, technical reports) which may not be indexed in these databases. Websites of organizations like WHO, CDC, or manufacturers might be relevant.\n5.  **Clinical Trials Registries:** Search clinical trial registries (e.g., ClinicalTrials.gov, WHO ICTRP) for ongoing or unpublished studies.\n6.  **De-duplication:** Once you run searches in multiple databases and export the results to a reference manager (like EndNote, Zotero, Rayyan), you\u0027ll need to remove duplicate entries.\n7.  **Consult a Librarian:** A health sciences librarian is an invaluable resource for refining search strategies and identifying additional databases or search techniques.\n\nBy following this structured approach, you\u0027ll build a robust and transparent search strategy for your systematic review. Good luck!"}' published-date="{DateTime.UtcNow:HH:mm}"
/>

## Analysis

This comparison demonstrates the different approaches each AI model takes when responding to the same prompt. Here are the key differences observed:

### Response Characteristics

**ChatGPT**: Provides a direct response with 27 sentences. 

**Gemini**: Provides a detailed response with 61 sentences. 

## Key Takeaways

- Each model brings unique strengths to this type of query
- Response styles vary significantly between models
- Consider your specific use case when choosing between these models

## Try This Comparison Yourself

Want to test these models with your own prompts? Visit [SNEOS.com](https://sneos.com) to compare AI responses side-by-side in real-time.

---

*This comparison was generated using the [SNEOS AI Comparison Tool](https://sneos.com)*
*Published: October 15, 2025 | Models: ChatGPT, Gemini*
